Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route?
Aim: CNS infections due to parasites often prove fatal. In part, this is due to inefficacy of drugs to cross the blood-brain barrier. Methods: Here, we tested intranasal and intravenous route and compared adverse effects of Amphotericin B administration, through blood biochemistry, liver, kidney and...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
Wiley
2023
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/2827/ https://doi.org/10.4155/tde-2023-0032 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.sunway.eprints.2827 |
---|---|
record_format |
eprints |
spelling |
my.sunway.eprints.28272024-07-16T03:07:41Z http://eprints.sunway.edu.my/2827/ Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route? Siddiqui, Ruqaiyyah Ong, Timonthy Yu Yee * Maciver, Sutherland Khan, Naveed Ahmed QL Zoology RC Internal medicine RM Therapeutics. Pharmacology Aim: CNS infections due to parasites often prove fatal. In part, this is due to inefficacy of drugs to cross the blood-brain barrier. Methods: Here, we tested intranasal and intravenous route and compared adverse effects of Amphotericin B administration, through blood biochemistry, liver, kidney and brain histopathological evidence of toxicities in vivo post-administration. Results: It was observed that intranasal route limits the adverse side effects of Amphotericin B, in contrast to intravenous route. Conclusion: As parasites such as Naegleria fowleri exhibit unequivocal affinity toward the olfactory bulb and frontal lobe in the central nervous system, intranasal administration would directly reach amoebae bypassing the blood-brain barrier selectivity and achieve the minimum inhibitory concentration at the target site. Wiley 2023 Article PeerReviewed Siddiqui, Ruqaiyyah and Ong, Timonthy Yu Yee * and Maciver, Sutherland and Khan, Naveed Ahmed (2023) Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route? Therapeutic Delivery, 14 (8). pp. 485-490. ISSN 2041-6008 https://doi.org/10.4155/tde-2023-0032 10.4155/tde-2023-0032 |
institution |
Sunway University |
building |
Sunway Campus Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Sunway University |
content_source |
Sunway Institutional Repository |
url_provider |
http://eprints.sunway.edu.my/ |
topic |
QL Zoology RC Internal medicine RM Therapeutics. Pharmacology |
spellingShingle |
QL Zoology RC Internal medicine RM Therapeutics. Pharmacology Siddiqui, Ruqaiyyah Ong, Timonthy Yu Yee * Maciver, Sutherland Khan, Naveed Ahmed Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route? |
description |
Aim: CNS infections due to parasites often prove fatal. In part, this is due to inefficacy of drugs to cross the blood-brain barrier. Methods: Here, we tested intranasal and intravenous route and compared adverse effects of Amphotericin B administration, through blood biochemistry, liver, kidney and brain histopathological evidence of toxicities in vivo post-administration. Results: It was observed that intranasal route limits the adverse side effects of Amphotericin B, in contrast to intravenous route. Conclusion: As parasites such as Naegleria fowleri exhibit unequivocal affinity toward the olfactory bulb and frontal lobe in the central nervous system, intranasal administration would directly reach amoebae bypassing the blood-brain barrier selectivity and achieve the minimum inhibitory concentration at the target site. |
format |
Article |
author |
Siddiqui, Ruqaiyyah Ong, Timonthy Yu Yee * Maciver, Sutherland Khan, Naveed Ahmed |
author_facet |
Siddiqui, Ruqaiyyah Ong, Timonthy Yu Yee * Maciver, Sutherland Khan, Naveed Ahmed |
author_sort |
Siddiqui, Ruqaiyyah |
title |
Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route? |
title_short |
Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route? |
title_full |
Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route? |
title_fullStr |
Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route? |
title_full_unstemmed |
Can Amphotericin B-mediated effects be limited using intranasal versus intravenous route? |
title_sort |
can amphotericin b-mediated effects be limited using intranasal versus intravenous route? |
publisher |
Wiley |
publishDate |
2023 |
url |
http://eprints.sunway.edu.my/2827/ https://doi.org/10.4155/tde-2023-0032 |
_version_ |
1805893818757677056 |
score |
13.211869 |